Yu-Wei Chen, Lin Liu, Yuwei Cheng, Arlene Araneta, Neremiah Castano, Jennifer Gomez, Archana Ajmera, Huihui Ye, Karie Runcie, Deaglan Joseph McHugh, Kenneth Offit, Channing Judith Paller, Naomi Balzer Haas, Robert Allison Franklin, Roberto Pili, Juan Javier-Desloges, Christopher J. Kane, Tyler M Seibert, Aditya Bagrodia, Rana R. McKay. "A phase 2 study of neoadjuvant PARP inhibition followed by radical prostatectomy (RP) in patients with unfavorable intermediate-risk or high-risk prostate cancer with BRCA1/2 gene alterations (NePtune).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.tps430